Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity

Hepatology

Volumn 45, Issue 3, 2007, Pages 602-613

  Rollier, Christine S ^a   Paranhos Baccala, Glaucia ^b   Verschoor, Ernst J ^a   Verstrepen, Babs E ^a   Drexhage, Joost A R ^a   Fagrouch, Zahra ^a   Berland, Jean Luc ^b   Komurian Pradel, Florence ^b   Duverger, Blandine ^b   Himoudi, Nourredine ^b   Staib, Caroline ^c   Meyr, Marcus ^c   Whelan, Mike ^d   Whelan, Joseph A ^d   Adams, Victoria A ^d   Larrea, Esther ^e   Riezu, José I ^e   Lasarte, Juan José ^e   Bartosch, Birke ^f   Cosset, Francois L ^f   Spaan, Willy J M ^g   Diepolder, Helmut M ^h   Pape, Gerd R ^h   Sutter, Gerd ⁱ   Inchauspe, Genevieve ^b   Heeney, Jonathan L ^a,j   more..

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b BIOMÉRIEUX   (France)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF NAVARRA   (Spain)

^f UNIVERSITÉ DE LYON   (France)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ PAUL EHRLICH INSTITUT   (Germany)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HEPATITIS C VACCINE; RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHIMPANZEE; CHRONICITY; CONTROLLED STUDY; HEPATITIS C; IMMUNE RESPONSE; IMMUNIZATION; LIVER BIOPSY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; TH2 CELL; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, VIRAL; APOPTOSIS REGULATORY PROTEINS; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; CYTOKINES; DNA, VIRAL; HEPACIVIRUS; HEPATITIS C; PAN TROGLODYTES; VIRAL HEPATITIS VACCINES; VIRAL LOAD;

EID: 33947409611     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21573     Document Type: Article

References (55)

1. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. HEPATOLOGY 2000;31:777-782.
2. De Francesco R, Rice CM. New therapies on the horizon for hepatitis C: are we close? Clin Liver Dis 2003;7:211-242, xi.
3. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-229.
4. Cox AL, Mosbruger T, Mao Q, Liu Z, Wang XH, Yang HC, et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 2005;201:1741-1752.
5. Diepolder HM, Gerlach JT, Zachoval R, Hoffmann RM, Jung MC, Wierenga EA, et al. Immunodominant CD4+ T-cell epitope within non-structural protein 3 in acute hepatitis C virus infection. J Virol 1997;71:6011-6019.
6. Erickson AL, Kimura Y, Igarashi S, Eichelberger J, Houghton M, Sidney J, et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 2001;15:883-895.
7. Folgori A, Capone S, Ruggeri L, Meola A, Sporeno E, Ercole BB, et al. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nat Med 2006;12:190-197.
8. Ray SC, Fanning L, Wang XH, Netski DM, Kenny-Walsh E, Thomas DL. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 2005;201:1753-1759.
9. Tester I, Smyk-Pearson S, Wang P, Wertheimer A, Yao E, Lewinsohn DM, et al. Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 2005;201:1725-1731.
10. Youn JW, Park SH, Lavillette D, Cosset FL, Yang SH, Lee CG, et al. Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee. HEPATOLOGY 2005;42:1429-1436.
11. Thomson M, Nascimbeni M, Havert MB, Major M, Gonzales S, Alter H, et al. The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity. J Virol 2003;77:862-870.
12. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004;305:872-874.
13. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 2002;99:15661-15668.
14. Shoukry NH, Cawthon AG, Walker CM. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol 2004;58:391-424.
15. Manigold T, Shin EC, Mizukoshi E, Mihalik K, Murthy KK, Rice CM, et al. Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 2006;107:4424-4432.
16. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995;346:1006-1007.
17. Rollier C, Depla E, Drexhage JA, Verschoor EJ, Verstrepen BE, Fatmi A, et al. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response. J Virol 2004;78:187-196.
18. Nevens F, Roskams T, Van Vlierberghe H, Horsmans Y, Sprengers D, Elewaut A, et al. A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C. HEPATOLOGY 2003;38:1289-1296.
19. Puig M, Major ME, Mihalik K, Feinstone SM. Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection. Vaccine 2004;22:991-1000.
20. Lechmann M, Liang TJ. Vaccine development for hepatitis C. Semin Liver Dis 2000;20:211-226.
21. Lasarte JJ, Sarobe P, Boya P, Casares N, Arribillaga L, de Cerio AL, et al. A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage. HEPATOLOGY 2003;37:461-470.
22. van Akker R, Balls M, Eichberg JW, Goodall J, Heeney JL, Osterhaus AD, et al. Chimpanzees in AIDS research: a biomedical and bioethical perspective. J Med Primatol 1993;22:390-392.
23. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 1990;87:9524-9528.
24. Himoudi N, Abraham JD, Fournillier A, Lone YC, Joubert A, Op De Beeck A, et al. Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection. J Virol 2002;76:12735-12746.
25. Rollier C, Verschoor EJ, Paranhos-Baccala G, Drexhage JA, Verstrepen BE, Berland JL, et al. Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting. J Infect Dis 2005;192:920-929.
26. Staib C, Drexler I, Ohlmann M, Wintersperger S, Erfle V, Sutter G. Transient host range selection for genetic engineering of modified vaccinia virus Ankara. Biotechniques 2000;28:1137-1142,1144-1146,1148.
27. Staib C, Sutter G. Live viral vectors: vaccinia virus. Methods Mol Med 2003;87:51-68.
28. Staib C, Drexler I, Sutter G. Construction and isolation of recombinant MVA. Methods Mol Biol 2004;269:77-100.
29. Li JS, Tong SP, Vitvitski L, Lepot D, Trepo C. Evidence of two major genotypes of hepatitis C virus in France and close relatedness of the predominant one with the prototype virus. J Hepatol 1991;13(Suppl 4):S33-S37.
30. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudoparticles containing functional E1-E2 envelope protein complexes. J Exp Med 2003;197:633-642.
31. Lavillette D, Morice Y, Germanidis G, Donot P, Soulier A, Pagkalos E, et al. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol 2005;79:6023-34.
32. Koopman G, Mortier D, Hofman S, Niphuis H, Fagrouch Z, Norley S, et al. Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens. J Gen Virol 2004;85:2915-2924.
33. Krajden M, Zhao J, Bourke C, Scalia V, Gill P, Lau W. Detection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube sera. J Clin Microbiol 1996;34:2191-2195.
34. Komurian-Pradel F, Paranhos-Baccala G, Sodoyer M, Chevallier P, Mandrand B, Lotteau V, et al. Quantitation of HCV RNA using real-time PCR and fluorimetry. J Virol Methods 2001;95:111-119.
35. Andre P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, et al. Characterization of low- and very-low-densiry hepatitis C virus RNA-containing particles. J Virol 2002;76:6919-6928.
36. Komurian-Pradel F, Perret M, Deiman B, Sodoyer M, Lotteau V, Paranhos-Baccala G, et al. Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome. J Virol Methods 2004;116:103-106.
37. Larrea E, Riezu-Boj J, Gil-Guerrero L, Casares N, Aldabe R, Sarobe P, et al. Upregulation of indoleamine 2,3 dioxygenase in hepatitis C virus infection. J Virol 2007. doi:10.1128/JVI.02248-06.
38. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004;4:762-774.
39. Kojima M, Osuga T, Tsuda F, Tanaka T, Okamoto H. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees. Virology 1994;204:665-672.
40. Okamoto H, Kojima M, Okada S, Yoshizawa H, Iizuka H, Tanaka T, et al. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 1992;190:894-899.
41. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. HEPATOLOGY 1994;20:1131-1136.
42. Cox AL, Mosbruger T, Lauer GM, Pardoll D, Thomas DL, Ray SC. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. HEPATOLOGY 2005;42:104-112.
43. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999;117:933-941.
44. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001;120:512-524.
45. Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W, et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. HEPATOLOGY 2003;37:1189-1198.
46. Ulsenheimer A, Gerlach JT, Jung MC, Gruener N, Wachtler M, Backmund M, et al. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. HEPATOLOGY 2005;41:643-651.
47. Urbani S, Amadei B, Fisicaro P, Tola D, Orlandini A, Sacchelli L, et al. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. HEPATOLOGY 2006;44:126-139.
48. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001;194:1395-1406.
49. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000;191:1499-1512.
50. Urbani S, Boni C, Missale G, Elia G, Cavallo C, Massari M, et al. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol 2002;76:12423-12434.
51. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, Nobile M, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001;410:106-111.
52. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001;75:5550-5558.
53. Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, Missale G, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 2006;80:11398-11403.
54. Munn DH. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Curr Opin Immunol 2006;18:220-225.
55. Bowen DG, Walker CM. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J Exp Med 2005;201:1709-1714.